16-23445969-TAAAAAA-TAAAA
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP6_Moderate
The NM_153603.4(COG7):c.170-10_170-9delTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0365 in 1,393,646 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00074 ( 0 hom., cov: 25)
Exomes 𝑓: 0.040 ( 1 hom. )
Consequence
COG7
NM_153603.4 intron
NM_153603.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.490
Publications
2 publications found
Genes affected
COG7 (HGNC:18622): (component of oligomeric golgi complex 7) The protein encoded by this gene resides in the golgi, and constitutes one of the 8 subunits of the conserved oligomeric Golgi (COG) complex, which is required for normal golgi morphology and localization. Mutations in this gene are associated with the congenital disorder of glycosylation type IIe.[provided by RefSeq, May 2010]
COG7 Gene-Disease associations (from GenCC):
- COG7-congenital disorder of glycosylationInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
PM2
Variant has high frequency in the EAS (0.0718) population. However there is too low homozygotes in high coverage region: (expected more than 464, got 1).
BP6
Variant 16-23445969-TAA-T is Benign according to our data. Variant chr16-23445969-TAA-T is described in ClinVar as Benign. ClinVar VariationId is 701826.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COG7 | NM_153603.4 | c.170-10_170-9delTT | intron_variant | Intron 1 of 16 | ENST00000307149.10 | NP_705831.1 | ||
| COG7 | XM_017023870.2 | c.-26-10_-26-9delTT | intron_variant | Intron 1 of 16 | XP_016879359.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000744 AC: 96AN: 129118Hom.: 0 Cov.: 25 show subpopulations
GnomAD3 genomes
AF:
AC:
96
AN:
129118
Hom.:
Cov.:
25
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0868 AC: 13227AN: 152462 AF XY: 0.0896 show subpopulations
GnomAD2 exomes
AF:
AC:
13227
AN:
152462
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0402 AC: 50802AN: 1264500Hom.: 1 AF XY: 0.0410 AC XY: 25867AN XY: 630538 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
50802
AN:
1264500
Hom.:
AF XY:
AC XY:
25867
AN XY:
630538
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
1293
AN:
27844
American (AMR)
AF:
AC:
2231
AN:
35722
Ashkenazi Jewish (ASJ)
AF:
AC:
1002
AN:
22852
East Asian (EAS)
AF:
AC:
2603
AN:
35088
South Asian (SAS)
AF:
AC:
3380
AN:
74152
European-Finnish (FIN)
AF:
AC:
2525
AN:
38784
Middle Eastern (MID)
AF:
AC:
221
AN:
4796
European-Non Finnish (NFE)
AF:
AC:
35172
AN:
972682
Other (OTH)
AF:
AC:
2375
AN:
52580
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
5156
10311
15467
20622
25778
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1184
2368
3552
4736
5920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000743 AC: 96AN: 129146Hom.: 0 Cov.: 25 AF XY: 0.000885 AC XY: 55AN XY: 62140 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
AF:
AC:
96
AN:
129146
Hom.:
Cov.:
25
AF XY:
AC XY:
55
AN XY:
62140
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
10
AN:
35056
American (AMR)
AF:
AC:
12
AN:
12618
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
3108
East Asian (EAS)
AF:
AC:
2
AN:
4586
South Asian (SAS)
AF:
AC:
0
AN:
4102
European-Finnish (FIN)
AF:
AC:
36
AN:
7090
Middle Eastern (MID)
AF:
AC:
0
AN:
244
European-Non Finnish (NFE)
AF:
AC:
34
AN:
59782
Other (OTH)
AF:
AC:
0
AN:
1746
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.324
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
COG7 congenital disorder of glycosylation Benign:1
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.